PDGFRB and cholangiocarcinoma: PDGFRβ leads to transactivation of EGFR via the formation of a PDGFRβ/EGFR complex [56], and imatinib treatment inhibits PDGFRβ-mediated cell proliferation and tumor growth in CC cells [114].